Skip to content
Recall Observatory FDA recall evidence

Drug product

robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA 19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274; NDC 52244-449-10.

D-0009-2019

September 17, 2018

Class I

Product summary

Firm
Endo Pharmaceuticals, Inc.
Event
Event 81034
Status
Terminated
Classification
Class I
Quantity
2,856 bottles
Official record key
drug-enforcement:D-0009-2019

Official wording

Reason: Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."

Code information: Lot #: 216702P1, Exp 09/20; 220409P1, Exp 01/21

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Incorrect